0
0
3/30/23 at 2:02pm
Organization
European Pharmaceutical Review
27 words
0
Comments
A novel approach for delivering intrathecal and intravenous immunotherapy improved survival of patients with leptomeningeal disease (LMD).
You are the first to view
https://www.europeanpharmaceuticalreview.com/news/181065/novel-delivery-approach-demonstrates-efficacy-of-immunotherapy/
Create an account
or login to join the discussion